Global Amino Acid Metabolism Disorder Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 199313
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Amino Acid Metabolism Disorder Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Amino Acid Metabolism Disorder Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Amino Acid Metabolism Disorder Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Amino Acid Metabolism Disorder Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Arginine

Folic Acid

Vitamin B6 & B12

Thiamine

Vitamin D

Betaine

Carglumic Acid

Sapropterin Dihydrochloride

Others

Market segment by Application, can be divided into

Phenylketonuria

Maple Syrup Urine Disease

Argininosuccinic Acidemia

Citrullinemia

Homocystinuria

Market segment by players, this report covers

GlaxoSmithKline

Pfizer

AMINO

Merck

Recordati

DSM

Sanofi

Kyowa Hakko Kirin

BioMarin

Swedish Orphan Biovitrum

Shine Star (Hubei) Biological Engineering

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Amino Acid Metabolism Disorder Drug

1.2 Classification of Amino Acid Metabolism Disorder Drug by Type

1.2.1 Overview: Global Amino Acid Metabolism Disorder Drug Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type in 2020

1.2.3 Arginine

1.2.4 Folic Acid

1.2.5 Vitamin B6 & B12

1.2.6 Thiamine

1.2.7 Vitamin D

1.2.8 Betaine

1.2.9 Carglumic Acid

1.2.10 Sapropterin Dihydrochloride

1.2.11 Others

1.3 Global Amino Acid Metabolism Disorder Drug Market by Application

1.3.1 Overview: Global Amino Acid Metabolism Disorder Drug Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Phenylketonuria

1.3.3 Maple Syrup Urine Disease

1.3.4 Argininosuccinic Acidemia

1.3.5 Citrullinemia

1.3.6 Homocystinuria

1.4 Global Amino Acid Metabolism Disorder Drug Market Size & Forecast

1.5 Global Amino Acid Metabolism Disorder Drug Market Size and Forecast by Region

1.5.1 Global Amino Acid Metabolism Disorder Drug Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Amino Acid Metabolism Disorder Drug Market Size by Region, (2016-2021)

1.5.3 North America Amino Acid Metabolism Disorder Drug Market Size and Prospect (2016-2026)

1.5.4 Europe Amino Acid Metabolism Disorder Drug Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size and Prospect (2016-2026)

1.5.6 South America Amino Acid Metabolism Disorder Drug Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Amino Acid Metabolism Disorder Drug Market Drivers

1.6.2 Amino Acid Metabolism Disorder Drug Market Restraints

1.6.3 Amino Acid Metabolism Disorder Drug Trends Analysis

2 Company Profiles

2.1 GlaxoSmithKline

2.1.1 GlaxoSmithKline Details

2.1.2 GlaxoSmithKline Major Business

2.1.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product and Solutions

2.1.4 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 GlaxoSmithKline Recent Developments and Future Plans

2.2 Pfizer

2.2.1 Pfizer Details

2.2.2 Pfizer Major Business

2.2.3 Pfizer Amino Acid Metabolism Disorder Drug Product and Solutions

2.2.4 Pfizer Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Pfizer Recent Developments and Future Plans

2.3 AMINO

2.3.1 AMINO Details

2.3.2 AMINO Major Business

2.3.3 AMINO Amino Acid Metabolism Disorder Drug Product and Solutions

2.3.4 AMINO Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 AMINO Recent Developments and Future Plans

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business

2.4.3 Merck Amino Acid Metabolism Disorder Drug Product and Solutions

2.4.4 Merck Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Merck Recent Developments and Future Plans

2.5 Recordati

2.5.1 Recordati Details

2.5.2 Recordati Major Business

2.5.3 Recordati Amino Acid Metabolism Disorder Drug Product and Solutions

2.5.4 Recordati Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Recordati Recent Developments and Future Plans

2.6 DSM

2.6.1 DSM Details

2.6.2 DSM Major Business

2.6.3 DSM Amino Acid Metabolism Disorder Drug Product and Solutions

2.6.4 DSM Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 DSM Recent Developments and Future Plans

2.7 Sanofi

2.7.1 Sanofi Details

2.7.2 Sanofi Major Business

2.7.3 Sanofi Amino Acid Metabolism Disorder Drug Product and Solutions

2.7.4 Sanofi Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Sanofi Recent Developments and Future Plans

2.8 Kyowa Hakko Kirin

2.8.1 Kyowa Hakko Kirin Details

2.8.2 Kyowa Hakko Kirin Major Business

2.8.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product and Solutions

2.8.4 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Kyowa Hakko Kirin Recent Developments and Future Plans

2.9 BioMarin

2.9.1 BioMarin Details

2.9.2 BioMarin Major Business

2.9.3 BioMarin Amino Acid Metabolism Disorder Drug Product and Solutions

2.9.4 BioMarin Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 BioMarin Recent Developments and Future Plans

2.10 Swedish Orphan Biovitrum

2.10.1 Swedish Orphan Biovitrum Details

2.10.2 Swedish Orphan Biovitrum Major Business

2.10.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product and Solutions

2.10.4 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Swedish Orphan Biovitrum Recent Developments and Future Plans

2.11 Shine Star (Hubei) Biological Engineering

2.11.1 Shine Star (Hubei) Biological Engineering Details

2.11.2 Shine Star (Hubei) Biological Engineering Major Business

2.11.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product and Solutions

2.11.4 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Shine Star (Hubei) Biological Engineering Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Amino Acid Metabolism Disorder Drug Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Amino Acid Metabolism Disorder Drug Players Market Share

3.2.2 Top 10 Amino Acid Metabolism Disorder Drug Players Market Share

3.2.3 Market Competition Trend

3.3 Amino Acid Metabolism Disorder Drug Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Amino Acid Metabolism Disorder Drug Revenue and Market Share by Type (2016-2021)

4.2 Global Amino Acid Metabolism Disorder Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2016-2021)

5.2 Amino Acid Metabolism Disorder Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2026)

6.2 North America Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2026)

6.3 North America Amino Acid Metabolism Disorder Drug Market Size by Country

6.3.1 North America Amino Acid Metabolism Disorder Drug Revenue by Country (2016-2026)

6.3.2 United States Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

6.3.3 Canada Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

6.3.4 Mexico Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2026)

7.2 Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2026)

7.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Country

7.3.1 Europe Amino Acid Metabolism Disorder Drug Revenue by Country (2016-2026)

7.3.2 Germany Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

7.3.3 France Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

7.3.5 Russia Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

7.3.6 Italy Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2026)

8.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2026)

8.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region

8.3.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Region (2016-2026)

8.3.2 China Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

8.3.3 Japan Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

8.3.4 South Korea Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

8.3.5 India Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

8.3.7 Australia Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2026)

9.2 South America Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2026)

9.3 South America Amino Acid Metabolism Disorder Drug Market Size by Country

9.3.1 South America Amino Acid Metabolism Disorder Drug Revenue by Country (2016-2026)

9.3.2 Brazil Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

9.3.3 Argentina Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2026)

10.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2026)

10.3 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country

10.3.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Country (2016-2026)

10.3.2 Turkey Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

10.3.4 UAE Amino Acid Metabolism Disorder Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Amino Acid Metabolism Disorder Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Amino Acid Metabolism Disorder Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Amino Acid Metabolism Disorder Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Amino Acid Metabolism Disorder Drug Revenue (USD Million) by Region (2016-2021)

Table 5. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Region (2021-2026)

Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 7. GlaxoSmithKline Major Business

Table 8. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product and Solutions

Table 9. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Pfizer Corporate Information, Head Office, and Major Competitors

Table 11. Pfizer Major Business

Table 12. Pfizer Amino Acid Metabolism Disorder Drug Product and Solutions

Table 13. Pfizer Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. AMINO Corporate Information, Head Office, and Major Competitors

Table 15. AMINO Major Business

Table 16. AMINO Amino Acid Metabolism Disorder Drug Product and Solutions

Table 17. AMINO Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Merck Corporate Information, Head Office, and Major Competitors

Table 19. Merck Major Business

Table 20. Merck Amino Acid Metabolism Disorder Drug Product and Solutions

Table 21. Merck Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Recordati Corporate Information, Head Office, and Major Competitors

Table 23. Recordati Major Business

Table 24. Recordati Amino Acid Metabolism Disorder Drug Product and Solutions

Table 25. Recordati Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. DSM Corporate Information, Head Office, and Major Competitors

Table 27. DSM Major Business

Table 28. DSM Amino Acid Metabolism Disorder Drug Product and Solutions

Table 29. DSM Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Sanofi Corporate Information, Head Office, and Major Competitors

Table 31. Sanofi Major Business

Table 32. Sanofi Amino Acid Metabolism Disorder Drug Product and Solutions

Table 33. Sanofi Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Kyowa Hakko Kirin Corporate Information, Head Office, and Major Competitors

Table 35. Kyowa Hakko Kirin Major Business

Table 36. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product and Solutions

Table 37. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. BioMarin Corporate Information, Head Office, and Major Competitors

Table 39. BioMarin Major Business

Table 40. BioMarin Amino Acid Metabolism Disorder Drug Product and Solutions

Table 41. BioMarin Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Swedish Orphan Biovitrum Corporate Information, Head Office, and Major Competitors

Table 43. Swedish Orphan Biovitrum Major Business

Table 44. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product and Solutions

Table 45. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Shine Star (Hubei) Biological Engineering Corporate Information, Head Office, and Major Competitors

Table 47. Shine Star (Hubei) Biological Engineering Major Business

Table 48. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product and Solutions

Table 49. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Amino Acid Metabolism Disorder Drug Revenue (USD Million) by Players (2019-2021)

Table 51. Global Amino Acid Metabolism Disorder Drug Revenue Share by Players (2019-2021)

Table 52. Breakdown of Amino Acid Metabolism Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Amino Acid Metabolism Disorder Drug Players Head Office, Products and Services Provided

Table 54. Amino Acid Metabolism Disorder Drug Mergers & Acquisitions in the Past Five Years

Table 55. Amino Acid Metabolism Disorder Drug New Entrants and Expansion Plans

Table 56. Global Amino Acid Metabolism Disorder Drug Revenue (USD Million) by Type (2016-2021)

Table 57. Global Amino Acid Metabolism Disorder Drug Revenue Share by Type (2016-2021)

Table 58. Global Amino Acid Metabolism Disorder Drug Revenue Forecast by Type (2021-2026)

Table 59. Global Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2021)

Table 60. Global Amino Acid Metabolism Disorder Drug Revenue Forecast by Application (2021-2026)

Table 61. North America Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Amino Acid Metabolism Disorder Drug Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Amino Acid Metabolism Disorder Drug Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Amino Acid Metabolism Disorder Drug Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Amino Acid Metabolism Disorder Drug Picture

Figure 2. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type in 2020

Figure 3. Arginine

Figure 4. Folic Acid

Figure 5. Vitamin B6 & B12

Figure 6. Thiamine

Figure 7. Vitamin D

Figure 8. Betaine

Figure 9. Carglumic Acid

Figure 10. Sapropterin Dihydrochloride

Figure 11. Others

Figure 12. Amino Acid Metabolism Disorder Drug Revenue Market Share by Application in 2020

Figure 13. Phenylketonuria Picture

Figure 14. Maple Syrup Urine Disease Picture

Figure 15. Argininosuccinic Acidemia Picture

Figure 16. Citrullinemia Picture

Figure 17. Homocystinuria Picture

Figure 18. Global Amino Acid Metabolism Disorder Drug Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 19. Global Amino Acid Metabolism Disorder Drug Revenue and Forecast (2016-2026) & (USD Million)

Figure 20. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Region (2016-2026)

Figure 21. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Region in 2020

Figure 22. North America Amino Acid Metabolism Disorder Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Europe Amino Acid Metabolism Disorder Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 25. South America Amino Acid Metabolism Disorder Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 26. Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 27. Amino Acid Metabolism Disorder Drug Market Drivers

Figure 28. Amino Acid Metabolism Disorder Drug Market Restraints

Figure 29. Amino Acid Metabolism Disorder Drug Market Trends

Figure 30. GlaxoSmithKline Recent Developments and Future Plans

Figure 31. Pfizer Recent Developments and Future Plans

Figure 32. AMINO Recent Developments and Future Plans

Figure 33. Merck Recent Developments and Future Plans

Figure 34. Recordati Recent Developments and Future Plans

Figure 35. DSM Recent Developments and Future Plans

Figure 36. Sanofi Recent Developments and Future Plans

Figure 37. Kyowa Hakko Kirin Recent Developments and Future Plans

Figure 38. BioMarin Recent Developments and Future Plans

Figure 39. Swedish Orphan Biovitrum Recent Developments and Future Plans

Figure 40. Shine Star (Hubei) Biological Engineering Recent Developments and Future Plans

Figure 41. Global Amino Acid Metabolism Disorder Drug Revenue Share by Players in 2020

Figure 42. Amino Acid Metabolism Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 43. Global Top 3 Players Amino Acid Metabolism Disorder Drug Revenue Market Share in 2020

Figure 44. Global Top 10 Players Amino Acid Metabolism Disorder Drug Revenue Market Share in 2020

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 46. Global Amino Acid Metabolism Disorder Drug Revenue Share by Type in 2020

Figure 47. Global Amino Acid Metabolism Disorder Drug Market Share Forecast by Type (2021-2026)

Figure 48. Global Amino Acid Metabolism Disorder Drug Revenue Share by Application in 2020

Figure 49. Global Amino Acid Metabolism Disorder Drug Market Share Forecast by Application (2021-2026)

Figure 50. North America Amino Acid Metabolism Disorder Drug Sales Market Share by Type (2016-2026)

Figure 51. North America Amino Acid Metabolism Disorder Drug Sales Market Share by Application (2016-2026)

Figure 52. North America Amino Acid Metabolism Disorder Drug Revenue Market Share by Country (2016-2026)

Figure 53. United States Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Canada Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Mexico Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Europe Amino Acid Metabolism Disorder Drug Sales Market Share by Type (2016-2026)

Figure 57. Europe Amino Acid Metabolism Disorder Drug Sales Market Share by Application (2016-2026)

Figure 58. Europe Amino Acid Metabolism Disorder Drug Revenue Market Share by Country (2016-2026)

Figure 59. Germany Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. France Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. United Kingdom Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Russia Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Italy Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Asia-Pacific Amino Acid Metabolism Disorder Drug Sales Market Share by Type (2016-2026)

Figure 65. Asia-Pacific Amino Acid Metabolism Disorder Drug Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue Market Share by Region (2016-2026)

Figure 67. China Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Japan Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South Korea Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. India Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Southeast Asia Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Australia Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South America Amino Acid Metabolism Disorder Drug Sales Market Share by Type (2016-2026)

Figure 74. South America Amino Acid Metabolism Disorder Drug Sales Market Share by Application (2016-2026)

Figure 75. South America Amino Acid Metabolism Disorder Drug Revenue Market Share by Country (2016-2026)

Figure 76. Brazil Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Argentina Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Middle East and Africa Amino Acid Metabolism Disorder Drug Sales Market Share by Type (2016-2026)

Figure 79. Middle East and Africa Amino Acid Metabolism Disorder Drug Sales Market Share by Application (2016-2026)

Figure 80. Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue Market Share by Country (2016-2026)

Figure 81. Turkey Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. UAE Amino Acid Metabolism Disorder Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz